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Abstract Influenza epidemics are a serious global public
health and economic problem. The IFITM3 allele
(rs12252-C) was suggested as a population-based genetic
risk factor for severe influenza virus infection by
A(H1N1)pdm09. We analyzed the population genetics of
IFITM3 variants in the Portuguese general population
(n = 200) and Central Africans (largely Angolan)
(n = 148) as well as its association to influenza severity in
Portuguese patients (n = 41). Seven SNPs, within the
352 bp IFITM3 amplicon around rs12252, were identified.
SNP distributions in the Portuguese appeared at an interme-
diate level between the Africans and other Europeans.
According to HapMap, rs34481144 belongs to the same
linkage disequilibrium (LD) block as rs12252 and is in
strong LD with rs6421983. A negative association with se-
vere relative to mild disease was observed for allele
rs34481144-A, indicating a protective effect under the dom-
inant model. Moreover, haplotype Hap4 with rs34481144-A,
not including rs12252-C, was significantly associated to
mild influenza. Conversely, although with borderline signif-
icance, haplotype Hap1 with rs34481144-G, not including
rs12252-C, was associated to severe disease. Moreover, in
comparison to the general Portuguese population, statistical
significant differences in the frequencies of the protective
allele rs34481144-A in the severe disease group, the delete-
rious Hap1 in the mild disease group, and the protective
Hap4 in the severe disease group were observed. The pop-
ulation attributable risk (PAR) for the targeted rs34481144
allele or genotype was of 55.91 and 64.44% in the general
population and the mildly infected individuals, respectively.
Implication of these variants in disease phenotype needs
further validation, namely through functional analysis as is
discussed.
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Annual epidemics of human influenza cause significant mor-
bidity and mortality worldwide. Three to five million people
experience severe illness and 0.25 to 0.5 million people die of
influenza yearly (http://www.who.int/mediacentre/factsheets/
2003/fs211/en/). Frequent complications include lower
respiratory tract infections (e.g., pneumonia) that may result
in hospitalization and death.
In industrialized countries, severe influenza is generally lim-
ited to high-risk groups (elderly, chronically ill). However, ma-
jor changes in the viral genetic makeup, namely in the influenza
Avirus, have resulted in pandemics associated with severe out-
comes also amongst healthy younger age groups. The global
health and economic burdens represented by these pandemics
have led to increased efforts to understand why some people
develop severe disease while others do not. Susceptibility to
severe seasonal or pandemic influenza in humans is likely to
be polygenic and codetermined by pathogen characteristics,
prior infection history, comorbidities, and environmental factors
(Horby et al. 2012). Animal studies suggest that genetic control
of susceptibility to severe influenza is complex and not con-
trolled by a single locus, but some of the host genetic determi-
nants of susceptibility to severe disease may be common across
influenza viral subtypes (Horby et al. 2012).
Host type I interferons (IFNs) are cytokines essential to
survive acute viral infection through stimulation of antiviral
effectors (Trinchieri 2010). Amongst the effectors of type I
IFNs, the interferon-induced transmembrane proteins,
IFITM1, 2, and 3, are involved in (i) virus sequestration, (ii)
virus receptor blockade, and (iii) endocytosis/fusion restric-
tion, thus inhibiting the replication of several types of viruses
including the influenza Orthomyxovirus (Schoggins et al.
2011).
The IFITM3 SNP rs12252-C allele, which translates into a
truncated protein missing the first 21 amino-terminal amino
acid residues, has been associated to severe pandemic influ-
enza A(H1N1)pdm09 virus infection in patients from the UK
and China (Everitt et al. 2012; Zhang et al. 2013; Yang et al.
2015) as well as to mild influenza, but not severe
A(H1N1)pdm09 infection, in a European cohort (Mills et al.
2013). Population genetics studies suggested that this allele,
rare in European ancestry but very common in the Han
Chinese and Japanese, is a potentially strong population-
based risk factor (Zhang et al. 2013).
In the 1000 genomes allele frequency database (The 1000
Genomes Project Consortium 2012), the prevalence of SNP
rs12252-C is heterogeneously distributed amongst popula-
tions worldwide. This is true for the Iberian populations and
most African populations. The latter are particularly relevant,
as in tropical regions of the developing world, viral transmis-
sion continues year round with high fatality rates (http://www.
who.int/mediacentre/factsheets/2003/fs211/en/).
As part of the current global endeavor to understand how
host genetic determinants modulate the response to influenza
virus infection, this study aimed to contribute to the popula-
tion genetics of IFITM3 genetic variation around the rs12252
locus in the Portuguese general population and Central
African (largely Angolan) populations and to investigate its
association to influenza severity in Portuguese patients.
Materials and methods
Subjects
For the population genetics, the samples were convenience
samples obtained from an anonymized collection of the
Department of Human Genetics, Instituto Nacional de Saúde
Doutor Ricardo Jorge, and included 200 Portuguese general
population and 148 Central African individuals, for 57% (85/
148) of which at least one of the parents was Angolan.
For genetic association studies with influenza severity, 41
Portuguese patients with laboratory confirmed influenza
A(H1N1)pdm09 infection were selected and classified either
as Bmild cases^ receiving ambulatory treatment only or as
Bsevere cases^ requiring admission to intensive care units
(ICUs). Criteria for admission to ICUs included pneumonia
or dyspnea. Chronic medical conditions, identified as poten-
tial A(H1N1)pdm09 risk factors (Van Kerkhove et al. 2011),
in these patients included immunosuppression (cancer, HIV
infection, Crohn’s disease, and organ transplant), diabetes,
chronic respiratory conditions, e.g., asthma, and cardiovascu-
lar disease. For influenza laboratory diagnosis, viral nucleic
acid extraction from oropharyngeal swabs was performed
using the automated extractor EasyMag (bioMérieux, Lyon,
France) according to the manufacturer’s recommendations.
The presence of influenza virus was searched for by real-
time RT-PCR, using a protocol kindly provided by the
Health Protection Agency, UK. All the samples collected from
the hospitalized and community patients and associated data
were anonymized prior to investigation.
Genotyping
Human genomic DNA was extracted from peripheral leuko-
cytes using MagNA Pure LC (Roche Diagnostics GmbH,
Mannheim, Germany) and from nasopharyngeal swabs using
the QIAamp® Viral RNA Mini Kit (Qiagen, Hilden,
Germany). PCR amplification of the 352 bp fragment in the
first exon of the IFITM3 gene (DNA position chr11: 320,556–
320,907, GRCh38/hg38) was carried out using the forward
and reverse primers: 5′-GGAAACTGTTGAGAAACCGA
A-3′ and 5′- CATACGCACCTTCACGGAGT-3′ (Zhang
et al. 2013). The PCR products were purified and sequenced
with BigDye Terminator v1.1 Sequencing Standard Kit
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(Applied Biosystems, Portugal) and analyzed with the ABI
3130 XL Genetic Analyzer (Applied Biosystems, MA,
USA). Sequences were analyzed using FinchLab™
(Geospiza). Haplotypes were reconstructed from the genotyp-
ing data using the PHASE, version 2.1, program (Stephens
et al. 2001, Stephens and Donnelly 2003).
Association testing
Association of genetic variants to disease severity was
assessed by IFITM3 genotyping of the individuals with severe
influenza and those with mild influenza. The latter were con-
sidered to be a better control for the studies of association to
severe influenza, rather than the general Portuguese popula-
tion group, for which the status of influenza infection was
unknown. However, the frequencies of the SNPs and haplo-
types between each patients’ group and the general
Portuguese population were also compared. Hardy-Weinberg
equilibrium (HWE) calculations were performed in the gener-
al population and influenza patient groups. Only SNPs under
HWE and with minor allele frequency > 5% in both case and
control groups were analyzed for association.
Statistical analysis of genetic data was performed using R-
stats library in the R-Statistical package, R Development Core
Team (http://www.R-project.org). The chi-square test was
used for testing association under different genetic models.
As the chi-square assumptions did not always hold, due to
small sample size, the Fisher’s Exact Probability Test (two-
tailed) was also used. The odds ratio (OR) was calculated
under different genetic models to measure the risk of severe
influenza. To evaluate the possible confounding effects of age,
gender, and chronic medical condition, the chi-square test was
used to test for association of these factors to genotype as well
as to mild and severe influenza. Estimates of the statistical
powers for the effect size range of the chi-square test used in
association testing in our patient population (n = 41) were
obtained. The chi-square test was also used for analyzing the
frequencies of the SNPs and haplotypes between each pa-
tients’ group and the general Portuguese population.
Results of the genotype-to-phenotype association testing
were presented with the OR and confidence interval (CI) re-
vealing the degree of precision in the size of the effect. In this
study, the statistical significance must be interpreted with re-
serve due to the reduced sample size. Moreover, the expected
size of the effect for common Blow-penetrant^ variants such as
observed for SNP rs34481144 in the Portuguese population is
small (Alcaïs et al. 2009), making it more difficult to detect.
Therefore, we assumed, in the context of this preliminary
study and in the light of the current interest in the exploration
of the IFITM3 promoter variants for their effect on viral influ-
enza clinical phenotypes in populations of different ancestries,
that it was justifiable to also report the 10% significance
levels, designated Bborderline^ as being suggestive but not
conclusive. For these the 90% CI of the OR was also calcu-
lated. It can further be recalled that the choice of the signifi-
cance level does not prove that the null hypothesis is either
right or wrong (Beaglehole et al. 1993). Moreover, to increase
stringency, the False Discovery Rate criterion (FDR) was per-
formed for the genetic models tested per SNP and for all the
haplotypes tested, although, given the non-random basis for
the study of the IFITM3 genetic loci, correction for multiple
testing would not be mandatory.
The population attributable risk (PAR), the fraction of the
population risk of severe influenza outcome attributable to the
studied allele or genotype, was estimated as follows:
PAR% = 100 × p (1 − OR) / [p (1 − OR) + 1], where p is
the prevalence of the studied allele in the general
population(or mild influenza patient group) and OR represents
an estimate of the relative risk of a severe infection outcome in
the population with the studied allele (or genotype) compared
to the population that does not carry the allele.
Gene expression
The biological significance of rs34481144, in altering gene
expression levels, was tested in a HeLa cell system using a
protocol adapted from Shen et al. (2013). For this a 347-bp
region of the IFITM3 promoter was amplified, using the for-
ward 5 ′-TATACTGCAGCTAGCGAGCCCTGAAC
CGGGACAGTG-3′ and reverse 5′-TATACTGCACTCGA
GTGGTGTCCAGCGAAGACCAGC-3′ primers, and cloned
into a pGL3 basic plasmid (Promega, Madison, WI, USA)
between the NheI and XhoI restriction sites. Site-directed mu-
tagenesis, of the c.-23G>A (rs34481144) site in the pGL3-
IFITM3 construct, was carried out using the forward and re-
verse primers, 5′-CCAGTAACCCGACCACCGCTGGTCTT
CGC-3′ and 5′-GCGAAGACCAGCGGTGGTCGGGTTAC
TGG-3′, respectively, in a reaction mix containing KOD Hot
Start buffer (1×) (Novagen TOYOBO), KOD Hot Start poly-
merase (1 U), MgSO4 1.5 mM (Novagen TOYOBO), dNTPs
10 mM (Promega, Madison, WI, USA), primers (0.3 μM
each) and 250 ng plasmid DNA. DNA was submitted to de-
naturation at 95 °C for 10 min, followed by 12 cycles at 95 °C
for 1 min, 55 °C for 1 min and 68 °C for 16 min, and a final
extension step at 68 °C for 10 min. After the mutagenesis
reaction, the original templates were digested with the DpnI,
1.5 h at 37 °C. The mutation was confirmed by DNA
sequencing.
For cell culture and luciferase assays, HeLa cells were
maintained in Dulbecco’s modified Eagle’s medium (Gibco
BRL, USA) supplemented with 10% fetal bovine serum, pen-
icillin (100 U/ml), and streptomycin (100U/ml). Twenty-four-
hour cultured HeLa cells, seeded in 48-well plates, were
transfected with the constructed pGL3-IFITM3 and the
pGL4.70hCMV plasmids, using Lipofectamine 2000
(Invitrogen, USA) in GIBCO™ in Opti-MEM I Reduced-
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Serum Medium (Gibco BRL, USA). Assays were performed
on cells treated at 20 h, or not, with human recombinant IFN-γ
or IFN-α (Alpha 2a) (final concentration of 100 pg/ml and
100 ng/ml). Firefly luciferase and renilla luciferase (via
pGL3-basic and pGL4.70hCMV, respectively) luminescences
were sequentially measured using a Dual-Luciferase Reporter
Assay System (Promega, USA). Results were expressed as the
ratio of light units of firefly luciferase activity over light units
of renilla luciferase activity. All experiments were performed
in triplicate and repeated three times.
Results
A total of seven SNPs were detected in the IFITM3 352 bp
amplicon. These included four previously described varia-
tions, namely SNP rs34481144, c.-23G>A (5′UTR), two syn-
onymous SNPsrs12252.c.42T>C (p.Ser14Ser) and
rs11553885, c.165C>T (p.Pro55Pro), and a missense SNP
rs1136853, c.9C>A (p.His3Gln). In addition, three synony-
mous variations were identified, namely c.33T>C
(p.Pro11Pro), c.51C>T (p.Pro17Pro), and c.60T>C
(p.Tyr20Tyr) (Supplementary Fig. 1). The c.33T>C
(p.Pro11Pro) variant is a novel, previously unreported SNP
in DNA position 320781, and was only found in heterozygos-
ity once in the Portuguese mild influenza patient group.
Thec.51C>T and c.60T>C variants, previously referred as
rs56323507and rs56020216, respectively (Everitt et al.
2012), were detected in heterozygosity simultaneously in only
one individual in the Central African group also harboring a
rs11553885c.165C>T variant. The allele distribution of these
SNPs in the study populations and 1000 genomes project
(when applicable) is summarized in Table 1. Hardy-
Weinberg equilibrium was verified in all instances except in
Central Africans who present a statistically significant homo-
zygote excess for SNP rs11553885 (Table 1).
Our general population genetics study contributed to better
delineate the IFITM3 genetic variation profile around rs12252
reported in the 1000 genomes project database. In fact, the
allele and genotype distributions of SNPs rs12252,
rs1136853, and rs34481144 place the Portuguese in an inter-
mediate position between the other Europeans and the sub-
SaharanAfricans, whereas the Central Africans closely resem-
ble the other African populations as reported in the 1000 ge-
nomes project (Supplementary Fig. 2; Table 1).
The association studies of allele and genotype frequencies
with severe influenza relative to mild influenza were carried
out for the three SNPs with minor allele frequency (MAF)
> 5% in the Portuguese influenza A(H1N1) patients with se-
vere and mild disease, namely rs12252, rs1136853, and
rs34481144, assuming dif feren t genet ic models
(Supplementary Table 2). Results showed a statistical signifi-
cant protective effect of the rs34481144-A allele against
severe influenza under the dominant model (OR = 0.26;
95% CI 0.07–0.97) and a borderline statistical significant ef-
fect for the overdominant model (OR = 0.27; 90% CI 0.09–
0.82). Moreover, possibly due to lack of power (the maximum
power in our study was 50%), these results did not resist the
FDR criterion.
Since, from our analysis, age and gender were not associ-
ated with genotype, also confirming the lack of evidence that
the IFITM3 allele or genotype frequencies vary with these
factors, there was no evidence of need to adjust for a con-
founding effect by these factors. Moreover, there was no ad-
justment for confounding by chronic medical conditions, as
this factor was not associated with the disease severity pheno-
types in our study. Given that the absence of the allele
rs34481144-A appeared to represent an increased risk of se-
vere disease, we estimated the PAR, the proportion of severe
influenza cases that would be preventable if all the individuals
in the population had the protective allele. According to our
results, 55.91 and 64.44% of the risk of severe infection are
attributable to the absence of the allele rs34481144-A, respec-
tively, in the general population and the mildly infected indi-
viduals. No significant association was found with the other
two SNPs, although there seems to be a trend of the allele
rs12252-C being associated to increased risk of severe influ-
enza disease, as previously reported in other populations.
Haplotype reconstruction data is summarized in the
Supplementary Table 1. Twenty-one haplotypes were identi-
fied in the various population groups analyzed. Haplotype-1
(Hap1) was the most frequent haplotype across all the study
groups, ranging from 0.46 to 0.70 in frequency. A number of
haplotypes (5, 6, and 21) not observed in the Portuguese gen-
eral population were detected in the Portuguesemild influenza
patients albeit at low frequencies (< 3%). Three haplotypes (2,
8, and 20) were detected in severe influenza, whereas they
were not observed in the mild influenza cases. Genetic asso-
ciation studies to increased risk of severe influenza were car-
ried out only for the three major haplotypes, with frequencies
above 5%, in the population groups under study, Portuguese
general population and A(H1N1) influenza patients. For
Hap1, as a deleterious genetic factor against influenza sever-
ity, an association with influenza severity, relative to mild
influenza, was observed with borderline statistical signifi-
cance (OR = 2.41; 90% CI 1.14–5.08) (Table 2). For
haplotype-4 (Hap4), as a protective genetic factor against in-
fluenza severity, a statistical significant association was ob-
served (OR = 0.29; 95% CI 0.10–0.82) (Fig. 1; Table 2). For
Hap4, the chi-square test resisted the FDR criterion.
Analysis of the frequencies of SNPs between each patients’
group and the general Portuguese population, showed, in a
dominant model of inheritance, a borderline statistical signif-
icant difference in the distribution of the SNP rs34481144-A
allele, in the severe disease group compared to that observed
in the general Portuguese population (p = 0.071). Concerning
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the haplotypes, the distribution of the deleterious Hap1 in the
mild disease group was significantly different from that ob-
served in the general Portuguese population (p = 0.017)
whereas the distribution of the protective Hap4 in the severe
disease group was significantly different than that observed in
the general Portuguese population (p = 0.016).
Linkage disequilibrium (LD) patterns of genetic variants in
the region around rs34481144 according to HapMap were
visualized in the population with northern and western
European ancestry (CEU) using Haploview (Barret et al.
2005). The plot showed this SNP as part of a LD block that
included the SNP rs12252 (Fig. 2). This latter SNP was in
perfect LD with rs1136853 (r2 = 1), as confirmed in our
dataset. The targeted SNP rs34481144 was in strong LD with
rs6421983 (r2 = 0.88).We first analyzed in silico the transcrip-
tion factor binding preferences for the 5′UTR SNP
rs34481144 using the JASPAR open-access database
(Mathelier et al. 2014). The existence of a possible binding
site (Zinc Finger Protein 354C), where there would be in-
creased transcription with the allele rs34481144-A, justified
the IFITM3 in vitro transcription analysis of the major haplo-
types, with and without this allele (Hap1 and Hap4, respec-
tively). Under the conditions tested, no significant difference
of activity was observed with this assay, either with or without
interferon stimulation, IFN-α (Supplementary Fig. 3) or
IFN-γ (not shown). In silico analysis of the intronic
rs6421983 c.249+171G>A and c.249+171G>C variants,
using the Human Splicing Finder software (Desmet et al.
2009), did not reveal potential alterations of splicing.
Discussion
The IFITM proteins are viral restriction factors affecting sev-
eral stages of the virus replication cycle, namely viral-host
receptor binding, endocytosis, or late endosome fusion and
acidification (Brass et al. 2009; Weidner et al. 2010). In
humans, these small proteins, of approximately 130 amino
acids, are encoded by five genes: IFITM1, IFITM2, IFITM3,
IFITM5, and IFITM10, located as a cluster on chromosome
11p15.5. The first three are considered type I IFN effectors
(Lewin et al. 1991). However, IFITM3 expression is also in-
duced by multiple cytokine signals including type II IFNs
(Bailey et al. 2012) which is suggestive of it playing a central
role in protection against both viral (Schoggins et al. 2011;
Brass et al. 2009; Weidner et al. 2010; Bailey et al. 2012; Jia
et al. 2012) and bacterial infections (Shen et al. 2013). Several
studies on human influenza have associated the host’s IFITM
proteins to protection against viral infection and subsequent
disease severity (Everitt et al. 2012; Zhang et al. 2013; Yang
et al. 2015; Mills et al. 2013; Brass et al. 2009; Weidner et al.
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The population genetics study we carried out on
Portuguese general population, a Central African general pop-
ulation and Portuguese influenza A(H1N1)pdm09 patients,
identified seven SNPs within a 352-bp IFITM3 amplicon
around rs12252. The general population study corroborated
the SNP distributions reported in the 1000 genomes project
for all the SNPs described therein. Namely, the rs12252-C
variant appears less common in the European and sub-
Saharan populations than that reported in the Han Chinese,
whereas the rs34481144-A variant appears to be more




patients. Error bars correspond to
standard errors. The pie charts on
the right represent the genotype
distribution at SNP rs34481144 in
the two influenza severity groups
Fig. 2 LD patterns in the
genomic region around
rs34481144 according to
HapMap, visualized using the
Haploview software (Barret et al.
2005) in the population with
ancestry from northern and
western Europe (CEU). The
second LD block contained the
targeted SNP rs34481144
correlated with rs6421983
(r2 = 0.88) and two correlated
SNPs rs12252 and rs1136853
(r2 = 1.00). The minor allele
frequencies for these SNPs are as
follows: 0.495 for rs34481144,
0.485 for rs6421983, and 0.045
for both rs12252 and rs1136853
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common in populations of European descent and in sub-
Saharan populations, having low prevalence in the Asian pop-
ulations. Concerning the Portuguese population, it appears as
an intermediate population between the Africans and the other
Europeans reported in the 1000 genomes project. The depar-
ture from Hardy-Weinberg equilibrium of SNP rs11553885 in
Central Africans, in which an excess of homozygotes was
observed, may reflect one of several hypotheses whose rela-
tive likelihood would need to be assessed through power in-
crement as well as demographic data on population distribu-
tion. These hypotheses include that the locus may be under
selective pressure, that Bnull alleles^ may be present, that in-
breeding may be common in the population, or that the exis-
tence of a population substructure.
The onset of the influenza A(H1N1)pdm09 pandemic in
2009 led to a subsequent report on the association of an
IFITM3 variant at SNP rs12252 with severe influenza disease
(Everitt et al. 2012). In their report, based on the analysis of 53
cases of severe A(H1N1)pdm09 or seasonal influenza virus
infection in patients from the UK, these authors suggested an
additive genetic model of association to the rs12252 minor
allele C. However, a recessive model of association was re-
ported in two ensuing studies; the first involving 32 cases of
severe infection compared to 51 mild A(H1N1)pdm09 influ-
enza cases in the Han Chinese (Zhang et al. 2013), and, the
second, in an extensive population genetics study of
theIFITM3gene, in a cohort of 34 severe A(H1N1) influenza
cases (requiring intensive care unit admission for pneumonia)
and over 5000 community acquired mild lower respiratory
tract infection and matched controls of European ancestry
(Mills et al. 2013).
In our genetic association study to influenza severity in the
Portuguese, the SNP rs12252 minor frequency allele C was
not significantly associated with severe influenza as previous-
ly reported (Everitt et al. 2012; Zhang et al. 2013; Yang et al.
2015; Mills et al. 2013). This could be due to lack of power in
our study. Indeed from our calculations based on published
data from a meta-analysis for rs12252 (Yang et al. 2015) and
on our population association studies revealing an expected
frequency of exposure of 6%, for a 95% confidence interval
and an 80% probability of detection of the risk of severe vs.
mild disease, we would require a sample of 586 individuals.
The targeted SNP rs34481144 was in the same linkage dis-
equilibrium (LD) block as rs12252 and showed strong LD
with rs6421983. In reports from other groups, no reference
was made to rs34481144, which we suggest to be protective
against severe forms of influenza. Moreover, the novel poly-
morphism c.33T>C (p.Pro11Pro) reported in this study was
not detected. This may have possibly been the result of meth-
odological differences, e.g., the selected primers not amplify-
ing the genome region where the SNP is located (Everitt et al.
2012) or because restriction fragment length polymorphism
(RFLP) SNP detection used instead of sequencing, as in our
study, would not detect the polymorphisms herein reported
nor novel variants (Mills et al. 2013). Also, the rs34481144
variant was probably not reported by Zhang and collaborators
in the Han Chinese study because this SNP appears to be more
common in populations of European descent, having low
prevalence in the Asian populations (Zhang et al. 2013),
which was also the case in the African populations as de-
scribed in the 1000 genomes project and observed in our
Central African population sample.
The genotype-to-phenotype association analysis, carried
out for the most frequent haplotypes in the Portuguese general
population in the severe relative to the mild influenza patient
groups, revealed a statistical significant association to severe
influenza (Hap1) or to mild influenza (Hap4), where this latter
association resisted the FDR criterion (OR = 0.29; 95% CI
0.10–0.82). Noteworthy is the fact that this latter haplotype
includes the protective allele rs34481144-A but not the sus-
ceptibility allele rs12252-C. Moreover, the results were sug-
gestive of an association of Hap1, which includes the
rs34481144-G allele but not the rs12252-C allele, to severe
influenza at a borderline significance level (OR = 2.41; 90%
CI 1.14–5.08). The association with influenza severity was
also observed for the SNP rs34481144 where the minor fre-
quency allele A indicated a protective effect against severe
influenza under the dominant model (OR = 0.26; 95% CI
0.07–0.97). Moreover, also corroborating these results, when
comparing the frequencies of the SNPs and haplotypes be-
tween each patients’ group and the general Portuguese popu-
lation, statistical significant differences were also observed,
namely the frequency of the protective SNP rs34481144-A
allele in the severe disease group was lower than expected
from analysis of the general population, the frequency of the
deleterious Hap1 in the mild disease group was lower than in
the general population, and the frequency of the protective
Hap4 in the severe disease group was lower than that observed
in the general Portuguese population.
The opposite tendencies, observed in the prevalence of the
minor alleles of the two SNPs associated on one hand with
severe influenza A(H1N1) infection (rs12252-C) and on the
other hand with protection against severe influenza A(H1N1)
infection (rs34481144-A) in two of the major geographic re-
gions studied in this context, namely Asia and Europe, respec-
tively, suggest that influenza exposure may have at one time
influenced these populations’ allele frequencies. The propor-
tion of severe cases that would be preventable if all the indi-
viduals in the population had the protective rs34481144-A
allele was estimated as 55.91 and 64.44% in the general pop-
ulation and the mildly infected individuals, respectively.
The genetic and molecular mechanisms of the IFITM that
interfere with viral and bacterial cycles are not yet fully un-
derstood (Tartour and Cimarelli 2015; Ranjbar et al. 2015).
Interestingly, Shen et al. (2013) identified a SNP in the
IFITM3 promoter (rs3888188) that responded to IFN-γ
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stimulation, although not in the vicinity of the IFN-gamma
activation site (GAS) element, and was associated with the
risk for pediatric tuberculosis in Han Chinese population. In
our study, the IFITM3 promoter SNP rs34481144 was associ-
ated with severe influenza virus infection. While this SNP
does not affect the consensus GAS or the IFN-stimulated re-
sponse element (ISRE) sequences (Darnell et al. 1994), an in
silico study of transcription factor binding preferences justi-
fied the in vitro transcription analysis of the major IFITM3
haplotypes. However, no significant difference of activity
was observed, either with or without IFN-α or IFN-γ
stimulation.
These findings point to important differences in the risk of
developing severe disease due to A(H1N1) influenza virus
infection in populations of different genetic background.
Confirmation in larger and different population sets is neces-
sary. Further studies of the SNP and loci in LD with
rs34481144 (rs6421983) are needed to determine possible
functional alterations, such as expression levels of IFITM3
in individuals with different genotypes, as this understanding
can help to identify novel targets for health interventions
aiming at influenza control.
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